Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

USE OF LIPOXYGENASE INHIBITORS AS ANTI-CANCER THERAPEUTIC AND INTERVENTION AGENTS

  • Read more about USE OF LIPOXYGENASE INHIBITORS AS ANTI-CANCER THERAPEUTIC AND INTERVENTION AGENTS
US Application 08/212,074
Filed on 1994-03-14

HEPARIN- AND SULFATIDE-BINDING PEPTIDES FROM THE TYPE I REPEATS OF HUMAN THROMBOSPONDIN AND CONJUGATES THEREOF

  • Read more about HEPARIN- AND SULFATIDE-BINDING PEPTIDES FROM THE TYPE I REPEATS OF HUMAN THROMBOSPONDIN AND CONJUGATES THEREOF
US Application 08/215,085
Filed on 1994-03-21

TREATMENT OF HUMAN TUMORS BY GENETIC TRANSFORMATION OF HUMAN TUMOR CELLS

  • Read more about TREATMENT OF HUMAN TUMORS BY GENETIC TRANSFORMATION OF HUMAN TUMOR CELLS
US Application 08/116,669
Filed on 1993-09-03

MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS

  • Read more about MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS
US Patent 5,874,560
Filed on 1994-04-22

PSEUDOMONAS EXOTOXINS(PE) AND CONJUGATES THEREOF HAVING LOWER ANIMAL TOXICITY WITH HIGH CYTOCIDAL ACTIVITY THROUGH SUBSTITUTION OF....

  • Read more about PSEUDOMONAS EXOTOXINS(PE) AND CONJUGATES THEREOF HAVING LOWER ANIMAL TOXICITY WITH HIGH CYTOCIDAL ACTIVITY THROUGH SUBSTITUTION OF....
US Patent 5,512,658
Filed on 1993-10-01

METHOD OF INDUCING CELL-MEDIATED PROTECTIVE IMMUNITY AGAINST HIV USING LOW DOSES OF IMMUNOGENS

  • Read more about METHOD OF INDUCING CELL-MEDIATED PROTECTIVE IMMUNITY AGAINST HIV USING LOW DOSES OF IMMUNOGENS
US Application 08/250,417
Filed on 1994-05-27

AZO DYE DERIVATIVES EXHIBITING ANTI-HIV ACTIVITY, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR USING THE SAME

  • Read more about AZO DYE DERIVATIVES EXHIBITING ANTI-HIV ACTIVITY, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR USING THE SAME
US Application 08/167,296
Filed on 1993-12-16

METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40

  • Read more about METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40
US Application 08/172,664
Filed on 1993-12-23

PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS

  • Read more about PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS
US Patent 5,635,599
Filed on 1994-04-08

FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS

  • Read more about FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS
US Application 08/189,552
Filed on 1994-02-01

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1592
  • Page 1593
  • Page 1594
  • Page 1595
  • Page 1596
  • Page 1597
  • Page 1598
  • Page 1599
  • Page 1600
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health